ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GWP GW Pharm.

735.00
0.00 (0.00%)
16 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
GW Pharm. LSE:GWP London Ordinary Share GB0030544687 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 735.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

GW Pharmaceuticals PLC Holding(s) in Company (7127L)

08/07/2014 10:18am

UK Regulatory


TIDMGWP

RNS Number : 7127L

GW Pharmaceuticals PLC

08 July 2014

 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 
---------------------------------------------------------------------------------------- 
 
 1. Identity of the issuer or the underlying               GW Pharmaceuticals plc 
  issuer 
  of existing shares to which voting rights 
  are 
  attached: 
-------------------------------------------------  ------------------------------------- 
 2 Reason for the notification (please tick the appropriate box or boxes): 
---------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                                        X 
-------------------------------------------------------------------------------  ------- 
 An acquisition or disposal of qualifying financial instruments 
  which may result in the acquisition of shares already issued to 
  which voting rights are attached 
-------------------------------------------------------------------------------  ------- 
 An acquisition or disposal of instruments with similar economic 
  effect to qualifying financial instruments 
-------------------------------------------------------------------------------  ------- 
 An event changing the breakdown of voting rights 
-------------------------------------------------------------------------------  ------- 
 Other (please 
  specify): 
------------------  -----------------------------------------------------------  ------- 
 3. Full name of person(s) subject                The Capital Group Companies, Inc. 
  to the 
  notification obligation: 
------------------------------------------  -------------------------------------------- 
 4. Full name of shareholder(s)                Capital Research and Management Company 
  (if different from 3.): 
------------------------------------------  -------------------------------------------- 
 5. Date of the transaction and date                         3 July 2014 
  on 
  which the threshold is crossed 
  or 
  reached: 
------------------------------------------  -------------------------------------------- 
 6. Date on which issuer notified:                           7 July 2014 
------------------------------------------  -------------------------------------------- 
 7. Threshold(s) that is/are crossed                          Above 10% 
  or 
  reached: 
------------------------------------------  -------------------------------------------- 
 
 
 
 8. Notified details: 
------------------------------------------------------------------------------------------------------------------------ 
 A: Voting rights attached to shares 
------------------------------------------------------------------------------------------------------------------------ 
 Class/type       Situation previous                    Resulting situation after the triggering 
  of               to the triggering                     transaction 
  shares           transaction 
 
  if possible 
  using 
  the ISIN CODE 
---------------  ------------------------------------  ----------------------------------------------------------------- 
                  Number          Number                Number     Number of voting         % of voting rights 
                   of              of                    of         rights 
                   Shares          Voting                shares 
                                   Rights 
---------------  --------------  --------------------  ---------  -----------------------  ----------------------------- 
                                                        Direct     Direct      Indirect     Direct           Indirect 
---------------    ----  ------  ------  -----  -----  ---------  ----------  -----------  ---------------  ------------ 
      ADRs 
 (US36197T1034)     1,947,957         23,375,484                               23,855,484                      10.111% 
---------------  --------------  --------------------  ---------  ----------  -----------  ---------------  ------------ 
 
 B: Qualifying Financial Instruments 
------------------------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------ 
 Type of financial        Expiration      Exercise/                      Number of voting              % of voting 
  instrument               date            Conversion Period              rights that may               rights 
                                                                          be 
                                                                          acquired if the 
                                                                          instrument is 
                                                                          exercised/ converted. 
-----------------------  --------------  -----------------------------  ----------------------------  ------------------ 
 
 
 C: Financial Instruments with similar economic effect to Qualifying Financial 
  Instruments (xv, xvi) 
------------------------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------ 
 Type of            Exercise      Expiration     Exercise/         Number of voting              % of voting rights 
 financial           price         date           Conversion        rights instrument 
 instrument                                       period            refers to 
-----------------  ------------  -------------  ----------------  ----------------------------  ------------------------ 
                                                                                                 Nominal        Delta 
-----------------  ------------  -------------  ----------------  ----------------------------  -------------  --------- 
 
 
 Total (A+B+C) 
------------------------------------------------------------------------------------------------------------------------ 
 Number of voting rights                                        Percentage of voting rights 
-------------------------------------------------------------  --------------------------------------------------------- 
                          23,855,484                                                    10.111% 
-------------------------------------------------------------  --------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the voting rights and/or 
  the 
  financial instruments are effectively held, if applicable: 
-------------------------------------------------------------------------------- 
 
   Holdings by Capital Research and Management Company SMALLCAP World Fund, 
   Inc 
 
 Proxy Voting: 
-------------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
---------------------------------------------------  --------------------------- 
 11. Number of voting rights proxy holder will 
  cease 
  to hold: 
---------------------------------------------------  --------------------------- 
 12. Date on which proxy holder will cease to 
  hold 
  voting rights: 
---------------------------------------------------  --------------------------- 
 
 
  13. Additional information: 
----------------------------------------  -------------------------------------- 
 14. Contact name:                         Christopher Aquino 
----------------------------------------  -------------------------------------- 
 15. Contact telephone number:             800-421-8511 
----------------------------------------  -------------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLEANXPEFXLEEF

1 Year Gw Pharmaceuticals Chart

1 Year Gw Pharmaceuticals Chart

1 Month Gw Pharmaceuticals Chart

1 Month Gw Pharmaceuticals Chart